Peptides that mimic protein epitopes are interesting drug candidates. However, the design of effective peptidic drugs is difficult for several reasons, such as the fast degradation of peptides, their high flexibility, and thus high entropy loss on binding to the target. We therefore propose an in silico method for the automated design of peptides that are optimal with respect to several objectives. We present a Pareto-based multiobjective evolutionary algorithm for in silico peptide design. Using a simple molecular model, we apply the method to the design of peptides that (a) mimic antibody epitopes of the proteins thrombin and blood coagulation factor VIII, respectively, that (b) are short, and (c) are conformationally stable.
INTRODUCTION

I
n organisms, peptides have important functions; e.g., they are signaling agents as in the cases of hormones or neurotransmitters, or have antibiotic effects as in the case of defensins (Lehrer, 2004) . Hence, it is not astonishing that peptides are also used as drugs, be it as "biologicals" such as the classical peptide drug insulin, or, as newly developed peptides, a recent example being the HIV fusion inhibitor T20 (Hardy and Skolnik, 2004) .
Despite these successes, peptides are not ideal drugs because their medical use is hampered by several drawbacks. For instance, they are relatively large and hydrophilic and hence do not cross biological barriers with ease, they are often flexible and thus their binding to a target is entropically unfavorable, and they also may be destroyed quickly by peptidases.
Effective peptidic drugs could be obtained from an optimization process that takes into account several objectives. The first objective or objectives could refer to the fulfillment of a specific molecular function, such as the binding to a target protein. Such an objective may be the affinity to a given binding pocket on the target protein. The quantification of the fulfillment in this case requires the 3D structure of the binding pocket, information which often is not available. A viable alternative objective can be the similarity to an epitope assumed to bind into that pocket of the target protein (Oomen et al., 2003) ; fulfillment of this objective corresponds to the design of a so-called mimotope (Geysen et al., 1986) . In the following, "mimotope" refers to a part of a peptide that mimics the conformation of an epitope whereas the whole peptide molecule containing this mimotope is refered to as "epitope-mimicking peptide" or "mimotope peptide." The second group of objectives should capture more general features such as bio-availability, peptidase resistance, etc.
A quasi-natural approach for the finding of optimal peptide sequences is the use of evolutionary algorithms, and there have been a number of reports on the successful optimization of nonpeptidic drugs (Globus et al., 1999; Goh and Foster, 2000) and peptides with respect to a single objective using such methods (Jones, 1994; Campbell et al., 2002) . Here we show that it is possible to generalize the evolutionary approach to the systematic solution of the multiobjective problem described above, with the three objectives being maximization of similarity to an epitope, maximization of stability, and minimization of peptide chain length.
Even in single objective optimization there typically exist different objectives, but these are aggregated to a single objective function, most frequently using weighted sums. This requires a priori knowledge of the right weights, which usually is not available or is difficult to obtain because of incommensurable objectives. Another possibility is the repetition of optimization runs using different weight distributions; this is time consuming and often not satisfactory because even small differences in weights can cause large differences in the resulting optima. In contrast, in multiobjective optimization, a number of objectives can be addressed simultaneously, and by identifying the Pareto front (Pareto, 1897; Deb, 2001) , representatives for all possible tradeoffs between objectives can be found. A detailed description of the concepts involved in multiobjective optimization is given in the appendix Multiobjective Optimization. Considering this advantage, it could be promising to reimplement some single objective applications in a multiobjective fashion (O'Hagan et al., 2005) . Nevertheless, multiobjective approaches are still not widely used. In the wider area of bioinformatics, there have been only a few approaches that use multiobjective algorithms (Handschuh et al., 1998) , especially in the field of combinatorial library design (Gillet et al., 2002a (Gillet et al., , 2002b .
The focus of the work presented here was not the actual design of peptide mimotopes but the testing of principle features of the algorithm. Hence, we chose a coarse molecular lattice model described by Jernigan and coworkers (Miyazawa and Jernigan, 1996; Raghunathan and Jernigan, 1997) which made it possible to carry out many evolutionary optimization runs with different sets of algorithmic parameters and, for comparison, complete enumerations of conformations. Nonetheless, the molecular model has enough detail to allow for a representation of some key characteristics of real peptides (Raghunathan and Jernigan, 1997). Therefore we selected two real test cases: the design of peptides that mimic certain antibody epitopes of two blood-borne proteins, thrombin and the C2-domain of blood coagulation factor VIII (FVIII). For both proteins, the native 3D structures of the epitopes are known (Baerga-Ortiz et al., 2002; Spiegel et al., 2001) .
ALGORITHM
The approach presented here was devised to find mimotope peptides that in their minimum (free) energy states have maximum similarity to a linear epitope of amino acids in its native conformation. This is the specific functional objective. In addition, these peptides are required to fulfill two other objectives: they should have stable conformations to minimize the entropy loss on binding to the target, and they should be as small as possible to maximize bio-availability. To address all three objectives simultaneously, we have developed an evolutionary multiobjective optimization system. It comprises three modules: a sequence design module for evolutionary sequence generation; a sequence design module which calls a peptide folding module for finding the minimum energy conformation of the generated sequences; and finally, a peptide folding module which calls an energy module that computes the (free) energy of a given conformation (see Fig. 1 ). Our algorithm is embedded into the generic multiobjective optimization environment KEA. 1
Sequence design module
The topmost layer of our system is inspired by genetic programming and related methods (Banzhaf et al., 1998) . It follows the scheme shown in Fig. 2 . A set of candidate sequences (individuals) is initialized that 
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form the starting population of an artificial evolutionary process. In each algorithmic iteration (generation), new sequences are created by the variation operators mutation, crossover, and swapping. Additionally, an elitism function is used to ensure that a small amount of successful "genetic material" is introduced from an archive of previous generations into the next generation. The fitness of each sequence is rated by the folding module. The sequences for the next generation are selected in a tournament (Bäck, 1996) and are also copied to the archive.
EDI
Most sequence modification operators rely on an attempt to modularize sequences into structural or functional motifs. As in the concept of explicitly defined introns (EDI) (Nordin et al., 1995) , we assign to each peptide bond a probability p m(i) ∀i ∈ 1, . . . , |x| − 1 of being the start or end of a motif. Initially, these probabilities are uniformly distributed. Operations on bond i, e.g., crossover or swapping, that generate new successful sequences increase the probability p m(i) [Eq. (1) ]. Afterwards, all probabilities are normalized [Eq. (2)].
EDIs, to some extent, prevent motifs emerging during the evolutionary process from being destroyed by evolutionary operators.
Crossover
One of the evolutionary operators used to create new individuals is crossover. With this operator two individuals are recombined by merging their sequences. In our implementation, we use pairwise single point crossover (Deb, 2001 ): According to the EDI-probabilities, a crossover site is randomly chosen in both individuals; then new individuals are created by splitting the sequences at the chosen crossover sites and by joining the beginning of the first sequence with the ending of the second sequence and vice versa. This method in general leads to variations of sequences and sequence lengths. Crossover is used during recombination with probability p c ∈ [0.7, 1].
Mutation
In standard mutation, one amino acid of the candidate sequence is replaced by another one from a nonempty set (the mutation pool M). Each amino acid has the same probability p m of being replaced, namely, the reciprocal of the sequence length. Following the idea of automatically defined functions (ADF) (Koza, 1992 )-a concept stating that it can be advantageous to extend the mutation set by complex partsthe mutation pool not only comprises the 20 single amino acids but also a pool of short sequence stretches. Thus, an amino acid in a sequence may be replaced by other amino acids or by insertions (Fig. 3 ). This mutation pool itself undergoes a slower evolutionary process of its own including selection, mutation, and crossover. As selection criterion for good stretches, the degree of success of the individuals containing these stretches is used. Each stretch st receives a fitness value f mut (st), which is calculated from the number of times cho(st) it has been chosen and the number of times suc(st) it has succeeded in increasing an individual's fitness [Eq. (3)].
The first summand represents the ratio of success, while the second term guarantees an initial fitness f mut (st) > 0 for stretches which have not been chosen yet.
MULTIOBJECTIVE EVOLUTIONARY DESIGN OF PEPTIDIC MIMOTOPES 117
FIG. 3. Mutation scheme using a mutation pool: A single amino acid of a sequence is replaced by an amino acid motif, chosen from a pool of motifs.
Swapping
Individuals might contain good motifs in a suboptimal order. In this case, swapping of motifs can be an efficient means of optimization. The swapping procedure uses the EDI probabilities to identify motifs inside a sequence and interchanges the motifs thus defined (Fig. 4) .
Selection and elitism
The selection module aims at the identification of good individuals from the current population that afterwards are used to generate new individuals, following the notion that these are the most likely to create even better individuals. In this implementation, binary tournament selection is used: Two individuals are randomly picked from the old generation and compared using the following hierarchy of criteria:
1. Select the dominating individual according to the Pareto-dominance criterion (a detailed description of the Pareto-dominance criterion is given in the appendix Multiobjective Optimization). 2. Select the individual in the lesser crowded hypercube. 3. Select a randomly chosen individual.
The winner of this binary tournament may participate in generating offsprings that become individuals in the next generation. This process is repeated until the new population is filled.
Tournament selection is designed to preserve the probability of some nonoptimal individuals to be selected for a new generation. This is advantageous as it ensures the diversity of the genetic pool. On the other hand, the best individuals might perish by chance from the population due to the random nature of the selection, and hence the algorithm may fail to optimize. Therefore, the strategy of elitism (Deb, 2001) was   FIG. 4 . Scheme of swapping mutation: A sequence is divided into different, nonoverlapping motifs. During a swapping mutation, the order of these motifs is changed. adopted to guarantee that the best individuals are not lost. Specifically, in each generation, a fixed number of the best individuals is transferred from the archive of successful sequences to the current population.
Crowding measure including partial user preferences
Approximating the Pareto front itself is a multiobjective problem. It is generally assumed that if the user states no preferences, a solution set with minimal distance to the front and maximal objectivespace diversity is desired. Thus, the majority of multiobjective evolutionary algorithms implements an anticrowding strategy which prevents the clustering of solutions in the objective space and maintains a diverse set. The proposed algorithm uses the adaptive hypercube strategy which separates the occupied space into a number of equally spaced cubes. Each solution then is assigned the number of individuals sharing the same cube. In the selection process, this measure is used to compare mutually nondominating individuals and to give an emphasis to those in less crowded cubes.
Users have the possibility to assign importance values to individual objectives. Using these values, the hypercube grid is calculated with a bias to more interesting regions of the objective space (see Fig. 5 ). In effect, a still widespread front with a denser cover of individuals in the specified regions results. In the experiments, we chose stability and similarity to be more important than length.
Peptide folding module
This module is used to search for the most probable conformation of a given sequence and to estimate the stability of this conformation. In our implementation, we use simulated annealing (SA) (Kirkpatrick et al., 1983 ) with a linear cooling scheme. The new temperature T i+1 is computed from the old temperature T i , the iteration counter i cur , the number of allowed iterations i max , and the maximal and minimal allowed temperature in the system T max , T min (Eq. (4)). The SA is shown schematically in Fig. 6 . The algorithm generates conformational moves in a discretized search space (lattice model). A SA move is realized by a change of position of one randomly chosen amino acid to a new valid position in the lattice. Valid positions preserve the correct bond lengths and angles between sequence neighbors and avoid overlapping residues.
Energy module
The most probable conformation and its free energy are estimated using the third module, the peptide module. The folding module treats amino acid residues as points and peptides as self-avoiding chains of residues in a regular, three-dimensional cubo-octahedral lattice (Raghunathan and Jernigan, 1997), in which each lattice point has 12 neighbors. The free energy of a given conformation is calculated as the sum of interactions between neighboring residues in the lattice that are not adjacent in sequence. Long range interactions are not modeled. The interaction energy terms are taken from a 20 × 20 matrix of empirical contact potentials (Miyazawa and Jernigan, 1996) .
Objective functions
After having rated a number of candidate folds (SA iterations × number of conformational moves), the fold with the lowest free energy found by the peptide folding module is used to calculate the objective vector. Three different objectives are used as detailed in the following.
Degree of similarity
To measure the degree of similarity of a newly designed sequence seq with a predefined structural motif of size s(motif ), the motif is used as a search pattern. It is moved over the structure of the newly designed sequence in all possible positions and orientations. This total enumeration is possible because of the use of a lattice model; in fact, the CPU time spent on this enumeration can be neglected. For each position and orientation pos i , the number s i of amino acids matching on the lattice between the search pattern and the candidate peptide is counted. Then, the similarity score SIM(seq) is calculated using Equation (5). SIM(seq) values range from zero for no match to one for complete geometrical overlap of corresponding amino acids.
SIM(seq) = max ∀pos i s i s(motif )
Conformational stability
During calculation of the most probable conformation of a given sequence, a sample of conformations is drawn. This sample is used to approximate the partition function and thus to estimate the stability of the most probable conformation. The stability of this conformation X 0 with energy E 0 is assumed to be given by the estimated probability p(X 0 ) computed for a Boltzmann-distributed ensemble using Equation (6), where n is the number of computed conformations (sample size) and n(E i ) is the observed degeneracy of the state with energy E i in the sample.
Peptide length
We use minimum peptide length as the third objective. First, longer peptides have a lower bio-availability; second, the cost of synthesis increases with length; third, the longer the chain, the worse are sampling errors in computational optimization.
RESULTS AND DISCUSSION
We have applied our approach to the design of two lattice models of mimotope peptides: First, a peptide mimicking a sequence stretch, comprising residues 77 through 80 (ERNIE, cp. Table 2 ) of human thrombin (PDB 1A2C) that contains a part of a discontinuous epitope; this epitope has been determined experimentally (Baerga-Ortiz et al., 2002) . The second peptide was designed to mimic residues 2249 to 2254 (KSLLTS, cp. Table 2 ) of the FVIII protein (PDB 1IQD); this epitope is a linear part of a larger discontinuous epitope determined crystallographically (Spiegel et al., 2001) .
Prior to the actual simulation, the experimentally determined epitope conformations were modeled onto the lattice, to obtain the target for the similarity computation according to Equation (5). The C α atoms were placed at lattice positions such that the RMSD was minimized between the C α positions on the lattice and the actual positions that had been determined experimentally. The resulting lattice epitopes differ slightly from the structures recorded in the PDB files (in case of the thrombin epitope, we computed a RMSD of about 0.8 Å, cp. Fig. 7) .
After having transferred the two epitopes to the lattice, we applied the algorithm described above to the design of new sequences. Both simulations were run for 2,500 generations of sequence modification with a population of 30 individuals per generation. Each individual sequence was submitted to 750 cooling steps of simulated annealing with 20 conformational moves per step. This amounts to about 1.125 · 10 9 energy evaluations per run.
The parameters of both sequence design module and peptide folding module were tested using a full factorial experimental design. One hundred sixty shorter test runs were carried out and compared using the R2 metric (Hansen and Jaszkiewicz, 1998 ) (data not shown). It turned out that the size of the mutation pool and the mutation probability were the most sensitive parameters while crossover probability and population size had lower effects on the results. The best parameter combination is given in Table 1 and was used for the experiments. For the simulations, a 3.04 GHz XEON processor with 1 GB RAM running Linux and JDK 1.4.2_04 was used. On this machine, a run took approximately 9,200 min of CPU time (approximately 490 µs per SA move and free energy calculation).
We consider a match between an epitope and a mimotope x to be exact if both can be superimposed in such a way that for each of the residues of the epitope the mimotope has a residue at the same lattice position. This corresponds to SIM(x) = 1 according to Equation (5). In this sense, both runs identified peptides that exactly match the search pattern (cp. Fig. 7 ) and only differ in length and stability. For each run, the sequences of the Pareto-optimal peptides that exactly matched the search pattern are given in Table 2 .
FIG. 7.
C α traces of original thrombin epitope before conversion to the lattice (light gray) and lattice mimotope (dark gray). The lattice mimotope exactly corresponds to the lattice-converted original thrombin epitope (not shown). Interestingly, the moieties of the two molecules (black) are nonhomologous, which means that the algorithm has identified a new structure to stabilize the epitope. 
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Most of the mimotope peptides are relatively rich in hydrophobic residues. This makes sense as stability optimization is one of the objectives of our process and hydrophobic interactions are the strongest interactions available in the energy function of Miyazawa and Jernigan (1996) . In the test tube, this strong hydrophobicity would probably lead to solubility problems. Hence, solubility should be taken into account as an additional optimization objective.
A remarkable difference between thrombin and FVIII epitope-mimicking peptides is the distribution of the actual mimotope over the peptide sequence. Both template epitopes are linear, made up by continuous polypeptide stretches of the two proteins. Whereas all thrombin mimotope peptides identified by our method form the mimotope using the template stretch, several FVIII mimotope peptides are made up by discontinuous stretches, only partly using the template. Note that these discontinuous cases also can be superimposed exactly with the FVIII epitope on the lattice. This epitope dissection may in part be a modeling artifact since we have been using a coarse model that, e.g., neglects the internal structure of residues. Our similarity criterion is satisfied if all (point-like) residues of template epitope and mimotope match, whereas real residues are not pointlike but have internal degrees of freedom and have no spherical symmetry. Hence, two perfect matches in our coarse lattice model may expose different physicochemical faces to the binding partner. Although it could be an interesting feature of the algorithm that it is capable of generating solutions that are of such a qualitative difference, it might happen that for some inputs only fragmented mimotopes are generated. While this is not necessarily a problem, it could be addressed by an additional objective--the minimization of the number of mimotope-forming sequence stretches. Moreover, by providing an upper limit of the number of allowed stretches, this objective can be transformed into a constraint. By using a limit of one, only continuous mimotopes would be viable.
The question still remains why some of the FVIII mimotopes are split whereas the thrombin mimotopes are consistently continuous. The answer lies in the conformation of the template epitope. The thrombin epitope has the shape of an open "C" while in the FVIII epitope the two ends of the linear epitope peptide occupy neighboring lattice positions. By closing the gap between these two ends with a single "bond" and at the same time cleaving a bond between another pair of neighboring residues, we would arrive at a different peptide that nevertheless can be superimposed perfectly with the original one; i.e., the same residues occupy the same spatial positions as before. This phenomenon can indeed be observed in nature and has been termed "circular permutation" (Hahn et al., 1994) . The principle of circular permutation of sequences can be generalized by allowing the cleavage of not only one but of several bonds along the closed shape of the epitope. This is what we see in the case of the FVIII mimotopes: in the third and fourth mimotope peptide in Table 2 , the peptide chain leaves the closed shape of the epitope at certain positions, follows a loop that stabilizes the overall conformation, and returns at a lattice position adjacent to the one where it had left the epitope. The more open shape of the thrombin epitope makes such loop-out structures less likely.
Of the three objectives used, the stability criterion is the most complex one. We have therefore investigated this part of the criterion further. The main concern here was whether a criterion based on a sample of limited size (instead of the full partition function) allows a reliable estimation of conformational stability. Since we are using a lattice model and the peptides are short, we can carry out complete enumerations (CE) of conformational space and take this complete sample as the gold standard. With a test set of 100 randomly generated sequences of lengths of up to 15 and two independent samples of 8,000 conformations per sequence, we have compared the reliability of two sampling methods with this standard: Simulated Annealing (SA) sampling as it was used in the folding simulations to identify low energy conformations, and random sampling (RS) of conformational space. The latter method provides the best approximation for samples of given size. Table 3 summarizes the results. In the first line of Table 3 , we compare the correlation of the stability measure for the two sampling methods with CE. Simulated Annealing does not reach the correlation of random sampling, but lies not far below this value. The second and third line of the table show that with respect to two other relevant quantities SA is comparable to or better than RS: (1) the rank correlation; it captures differences between the sampling schemes in the tournament selection used to determine which sequences are copied to the archive and taken to the next generation; (2) the probability p c of making a correct comparison between two sequences in the tournament selection with respect to stability. Probability p c is defined in Equation (7) with the Cp-function given in Equation (8) as a measure for the quality of the samples. Table 3 shows that the right decision between two sequences based on the estimated stability is taken in more than 80% of cases. In summary, the stability criterion based on the sample gathered during the folding simulation works satisfactorily.
CONCLUSION
We have presented a method for the evolutionary design of mimotope peptides that simultaneously fulfill several criteria-stability, conformational similarity to the template epitope, length--to Pareto-optimality. We have successfully applied the method to the design of peptides that mimic epitopes of thrombin and human blood coagulation factor VIII on a lattice. The approach should be extended in at least two ways, namely, by considering solubility as additional criterion and by transferring the method to a more realistic molecular model.
APPENDIX: MULTIOBJECTIVE OPTIMIZATION
In most real-world optimization problems, one has to take a set of different and often incommensurable objectives into account. In contrast to standard single objective optimization, which tries to aggregate in an ad hoc manner the different objectives into a single objective, multiobjective optimization techniques allow one to optimize such a set of objectives simultaneously. As it is often difficult to choose good parameters for the aggregation, e.g., weights for a weighted sum approach, multiobjective techniques may be a better way to gain an overview of good, feasible solutions.
Multiobjective optimization aims at simultaneously optimizing m objectives F = (f 1 , . . . , f m ) : R n → R m depending on a decision vector of n parameters or decision variables x = (x 1 , . . . , x n ). These parameters may have to fulfill a set of k constraints g i (x) ≥ 0 ∀i ∈ {1, . . . , k}. Without loss of generality, it can be assumed that all objectives are to be minimized.
Since often a set of incommensurable objectives is regarded, one has to clarify what is meant by "optimal solutions." Pareto-dominance (Pareto, 1897; Deb, 2001 ) is a helpful notion in this respect:
Pareto-dominance. Given two objective vectors x and x it is said that x strictly dominates x (denoted x x ) if the following is true:
F (x ) = F (x ).
In terms of the Pareto-dominance, the set of best solutions for a given multiobjective optimization problem covers all Pareto-optimal solutions and is called the Pareto-set or Pareto-front.
Pareto-optimality and Pareto-set. A decision vector x * is called Pareto-optimal if
x ∈ X with x x * .
The set X * of all Pareto-optimal solutions, which is a subset to the set X of all feasible solutions, is called the Pareto-set X * = {x * ∈ X| x ∈ X : x x * }.
Multiobjective optimization approaches aim at identifying a good approximation of the Pareto-set for a given problem. This approximation is made up from all nondominated solutions found during the optimization process.
Nondominated solution. In a given set of solutions represented by vectors of decision variables, an individual x non−dom is nondominated if no other member of the set dominates x non−dom in terms of the Pareto-dominance relation.
